Glucaric acid

Glucaric acid is a lipid of Fatty Acyls (FA) class. Glucaric acid is associated with abnormalities such as Consumption-archaic term for TB and furuncle. The involved functions are known as Oxidation, Mutation, Process, Cell Growth and Anabolism. Glucaric acid often locates in BL21, Clone and host. The associated genes with Glucaric acid are MIOX gene, ISYNA1 gene, Genome and Candidate Disease Gene. The related experimental models are Knock-out.

Cross Reference

Introduction

To understand associated biological information of Glucaric acid, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Glucaric acid?

Glucaric acid is suspected in and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Glucaric acid

MeSH term MeSH ID Detail
Hemolysis D006461 131 associated lipids
Kidney Failure, Chronic D007676 51 associated lipids
Hypercalcemia D006934 13 associated lipids
Adenocarcinoma D000230 166 associated lipids
Dermatitis, Contact D003877 59 associated lipids
Lung Neoplasms D008175 171 associated lipids
Mycobacterium Infections D009164 7 associated lipids
Kidney Neoplasms D007680 29 associated lipids
Pancreatic Neoplasms D010190 77 associated lipids
Inflammation D007249 119 associated lipids
Mammary Neoplasms, Experimental D008325 67 associated lipids
Body Weight D001835 333 associated lipids
Edema D004487 152 associated lipids
Esophageal Neoplasms D004938 20 associated lipids
Precancerous Conditions D011230 48 associated lipids
Carbon Tetrachloride Poisoning D002252 12 associated lipids
Femoral Neck Fractures D005265 3 associated lipids
Hypotension D007022 41 associated lipids
Acute Kidney Injury D058186 34 associated lipids
Heart Failure D006333 36 associated lipids
Per page 10 20 50 100 | Total 85

PubChem Associated disorders and diseases

What pathways are associated with Glucaric acid

Lipid pathways are not clear in current pathway databases. We organized associated pathways with Glucaric acid through full-text articles, including metabolic pathways or pathways of biological mechanisms.

Related references are published most in these journals:

Pathway name Related literatures
Loading... please refresh the page if content is not showing up.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Glucaric acid?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Glucaric acid?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Glucaric acid?

There are no associated biomedical information in the current reference collection.

What genes are associated with Glucaric acid?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Glucaric acid?

Knock-out

Knock-out are used in the study 'Evolution-guided optimization of biosynthetic pathways.' (Raman S et al., 2014).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with Glucaric acid

Download all related citations
Per page 10 20 50 100 | Total 1061
Authors Title Published Journal PubMed Link
pmid:11794536
Hörl WH Re: Experience with a large dose (500 mg) of intravenous iron dextran and iron saccharate in peritoneal dialysis patients. 2001 Sep-Oct Perit Dial Int pmid:11757843
Duffy CI Iron sucrose or ferric gluconate? 2001 Am. J. Kidney Dis. pmid:11728988
Kaltwasser JP et al. Effect of recombinant human erythropoietin and intravenous iron on anemia and disease activity in rheumatoid arthritis. 2001 J. Rheumatol. pmid:11708414
Chandler G et al. Intravenous iron sucrose: establishing a safe dose. 2001 Am. J. Kidney Dis. pmid:11684551
Merbouh N et al. Facile nitroxide-mediated oxidations of D-glucose to D-glucaric acid. 2001 Carbohydr. Res. pmid:11675028
Talafant E et al. Serum gamma-glutamyl transpeptidase activity and urinary D-glucaric acid excretion in newborns in the first week of life. Effects of phenobarbital and nicethamide combination. 1976 Acta Paediatr Scand pmid:11634
Murchison LE et al. Effects of anticonvulsants and inactivity on bone disease in epileptics. 1975 Postgrad Med J pmid:1161672
pmid:11513584
Gasche C et al. Prediction of response to iron sucrose in inflammatory bowel disease-associated anemia. 2001 Am. J. Gastroenterol. pmid:11513178
pmid:11483144
Prakash S et al. Experience with a large dose (500 mg) of intravenous iron dextran and iron saccharate in peritoneal dialysis patients. 2001 May-Jun Perit Dial Int pmid:11475345
Pach J et al. New possibilities in scintigraphy detection of carbon monoxide cardiotoxicity. 2001 Prz. Lek. pmid:11450331
pmid:11390726
Levy G et al. Pharmacokinetics of acetaminophen in the human neonate: formation of acetaminophen glucuronide and sulfate in relation to plasma bilirubin concentration and D-glucaric acid excretion. 1975 Pediatrics pmid:1134883
Talafant E et al. Glucaric acid excretion as index of hepatic glucuronidation in neonates after phenobarbital treatment. 1975 Pediatr. Res. pmid:1134846
Stoves J et al. A randomized study of oral vs intravenous iron supplementation in patients with progressive renal insufficiency treated with erythropoietin. 2001 Nephrol. Dial. Transplant. pmid:11328902
pmid:11273875
Breymann C et al. Efficacy and safety of intravenously administered iron sucrose with and without adjuvant recombinant human erythropoietin for the treatment of resistant iron-deficiency anemia during pregnancy. 2001 Am. J. Obstet. Gynecol. pmid:11262469
Kosch M and Schaefer RM [Iron deficiency. When parenteral substitution?]. 2001 MMW Fortschr Med pmid:11247361
pmid:11217959
Charytan C et al. Efficacy and safety of iron sucrose for iron deficiency in patients with dialysis-associated anemia: North American clinical trial. 2001 Am. J. Kidney Dis. pmid:11157370
Johnson LL et al. Technetium-99m glucarate uptake in a swine model of limited flow plus increased demand. 2000 Nov-Dec J Nucl Cardiol pmid:11144474
Pollak A et al. Effect of intravenous iron supplementation on erythropoiesis in erythropoietin-treated premature infants. 2001 Pediatrics pmid:11134438
Fishbane S and Kowalski EA The comparative safety of intravenous iron dextran, iron saccharate, and sodium ferric gluconate. 2000 Nov-Dec Semin Dial pmid:11130261
Kao HH et al. Clinical characteristic of parenteral iron supplementation in hemodialysis patients receiving erythropoietin therapy. 2000 Chang Gung Med J pmid:11126152
Parkkinen J et al. Catalytically active iron and bacterial growth in serum of haemodialysis patients after i.v. iron-saccharate administration. 2000 Nephrol. Dial. Transplant. pmid:11071973
Matsuo E et al. Acid mucopolysaccharide metabolism in leprosy. 3. Hyaluronic acid mycobacterial growth enhancement, and growth suppression by saccharic acid and vitamin C as inhibitors of beta-glucuronidase. 1975 Jan-Mar Int. J. Lepr. Other Mycobact. Dis. pmid:1099016
van Iperen CE et al. Response of erythropoiesis and iron metabolism to recombinant human erythropoietin in intensive care unit patients. 2000 Crit. Care Med. pmid:10966249
Krafft A et al. Intravenous iron sucrose in two pregnant women with inflammatory bowel disease and severe iron deficiency anemia. 2000 Acta Obstet Gynecol Scand pmid:10949245
Gombotz H et al. Preoperative treatment with recombinant human erythropoietin or predeposit of autologous blood in women undergoing primary hip replacement. 2000 Acta Anaesthesiol Scand pmid:10903019
Van Wyck DB et al. Safety and efficacy of iron sucrose in patients sensitive to iron dextran: North American clinical trial. 2000 Am. J. Kidney Dis. pmid:10873877
Lai AA and Levy RH Pharmacokinetic description of drug interactions by enzyme induction: carbamazepine-clonazepam in monkeys. 1979 J Pharm Sci pmid:108383
Wargovich MJ et al. Efficacy of potential chemopreventive agents on rat colon aberrant crypt formation and progression. 2000 Carcinogenesis pmid:10837003
Fujita K et al. Establishment of Salmonella strain expressing catalytically active human UDP-glucuronosyltransferase 1A1 (UGT1A1). 2000 Life Sci. pmid:10821120
Wiersema AM et al. Early assessment of skeletal muscle damage after ischaemia-reperfusion injury using Tc-99m-glucarate. 2000 Cardiovasc Surg pmid:10799826
Gulick AM et al. Evolution of enzymatic activities in the enolase superfamily: crystallographic and mutagenesis studies of the reaction catalyzed by D-glucarate dehydratase from Escherichia coli. 2000 Biochemistry pmid:10769114
Monterrubio R et al. A common regulator for the operons encoding the enzymes involved in D-galactarate, D-glucarate, and D-glycerate utilization in Escherichia coli. 2000 J. Bacteriol. pmid:10762278
Fujii Y et al. Inhibition of liver metastases and tumor cell invasion in spontaneous liver metastasis model (LMFS) by sodium D-glucaro-delta-lactam (ND2001). 2000 Biomed. Pharmacother. pmid:10759292
Descombes E and Fellay G Improved response to erythropoietin therapy with long-term continuous iron supplementation. 2000 Nephron pmid:10657727
Bailie GR et al. Parenteral iron use in the management of anemia in end-stage renal disease patients. 2000 Am. J. Kidney Dis. pmid:10620537
Jahn M et al. The reaction of hyaluronic acid and its monomers, glucuronic acid and N-acetylglucosamine, with reactive oxygen species. 1999 Carbohydr. Res. pmid:10614067
Braun L et al. Different induction of gulonolactone oxidase in aromatic hydrocarbon-responsive or -unresponsive mouse strains. 1999 FEBS Lett. pmid:10606751
Yoshimi N et al. Inhibition of azoxymethane-induced rat colon carcinogenesis by potassium hydrogen D-glucarate. 2000 Int. J. Oncol. pmid:10601547
Lubberink M et al. Quantification aspects of patient studies with 52Fe in positron emission tomography. 1999 Appl Radiat Isot pmid:10581681
Mariani G et al. Detection of acute myocardial infarction by 99mTc-labeled D-glucaric acid imaging in patients with acute chest pain. 1999 J. Nucl. Med. pmid:10565778
Lim PS et al. Enhanced oxidative stress in haemodialysis patients receiving intravenous iron therapy. 1999 Nephrol. Dial. Transplant. pmid:10534512
Krafft A et al. Erythropoietic quality of maternal milk. 1999 Lancet pmid:10475225
Picaud JC et al. [Iron supplementation in preterm infants treated with erythropoietin]. 1999 Arch Pediatr pmid:10394459
Gasche C et al. Sequential treatment of anemia in ulcerative colitis with intravenous iron and erythropoietin. 1999 Digestion pmid:10343140